Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia
- PMID: 33470666
- PMCID: PMC9698117
- DOI: 10.1097/QCO.0000000000000715
Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia
Abstract
Purpose of review: We review the evidence on the use of noninvasive respiratory supports (noninvasive ventilation and high-flow nasal cannula oxygen therapy) in patients with acute respiratory failure because of severe community-acquired pneumonia.
Recent findings: Noninvasive ventilation is strongly advised for the treatment of hypercapnic respiratory failure and recent evidence justifies its use in patients with hypoxemic respiratory failure when delivered by helmet. Indeed, such interface allows alveolar recruitment by providing high level of positive end-expiratory pressure, which improves hypoxemia. On the other hand, high-flow nasal cannula oxygen therapy is effective in patients with hypoxemic respiratory failure and some articles support its use in patients with hypercapnia. However, early identification of noninvasive respiratory supports treatment failure is crucial to prevent delayed orotracheal intubation and protective invasive mechanical ventilation.
Summary: Noninvasive ventilation is the first-line therapy in patients with acute hypercapnic respiratory failure because of pneumonia. Although an increasing amount of evidence investigated the application of noninvasive respiratory support to hypoxemic respiratory failure, the optimal ventilatory strategy in this setting is uncertain. Noninvasive mechanical ventilation delivered by helmet and high-flow nasal cannula oxygen therapy appear as promising tools but their role needs to be confirmed by future research.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Figures
References
-
- Metlay JP, Waterer GW, Long AC, et al. . Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2019; 200:e45–e67. - PMC - PubMed
-
Current guidelines on diagnosis and treatment of community-acquired pneumonia. This is a landmark article for the best pharmacological management of such patients.
-
- Arabi YM, Arifi AA, Balkhy HH, et al. . Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 2014; 160:389–397. - PubMed
-
- Bellani G, Laffey JG, Pham T, et al. . LUNG SAFE Investigators, ESICM Trials Group Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA - J Am Med Assoc 2016; 315:788–800. - PubMed
-
- De Pascale G, Bello G, Tumbarello M, et al. . Severe pneumonia in intensive care. Curr Opin Pulm Med 2012; 18:213–221. - PubMed
-
- Torres A, Chalmers JD, Dela Cruz CS, et al. . Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive Care Med 2019; 45:159–171. - PMC - PubMed
-
A complete review on main issues regarding patients with severe community-acquired pneumonia. Useful update for ICU clinicians.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
